Revealing the contribution of somatic gene mutations to shaping tumor immune microenvironment
- 1 March 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 23 (3)
Abstract
Interaction between tumor cells and immune cells determined highly heterogeneous microenvironments across patients, leading to substantial variation in clinical benefits from immunotherapy. Somatic gene mutations were found not only to elicit adaptive immunity but also to influence the composition of tumor immune microenvironment and various processes of antitumor immunity. However, due to an incomplete view of associations between gene mutations and immunophenotypes, how tumor cells shape the immune microenvironment and further determine the clinical benefit of immunotherapy is still unclear. To address this, we proposed a computational approach, inference of mutation effect on immunophenotype by integrated gene set enrichment analysis (MEIGSEA), for tracing back the genomic factor responsible for differences in immunophenotypes. MEIGSEA was demonstrated to accurately identify the previous confirmed immune-associated gene mutations, and systematic evaluation in simulation data further supported its performance. We used MEIGSEA to investigate the influence of driver gene mutations on the infiltration of 22 immune cell types across 19 cancers from The Cancer Genome Atlas. The top associated gene mutations with infiltration of CD8 T cells, such as CASP8, KRAS and EGFR, also showed extensive impact on other immune components; meanwhile, immune effector cells shared critical gene mutations that collaboratively contribute to shaping distinct tumor immune microenvironment. Furthermore, we highlighted the predictive capacity of gene mutations that are positively associated with CD8 T cells for the clinical benefit of immunotherapy. Taken together, we present a computational framework to help illustrate the potential of somatic gene mutations in shaping the tumor immune microenvironment.Keywords
Funding Information
- National Key Research and Development Program of China (2018YFC2000100)
- National Natural Science Foundation of China (61873075, 32070673, 31871336)
- Heilongjiang Provincial Natural Science Foundation of Heilongjiang Province (YQ2019C012, YQ2021C026)
- Heilongjiang Postdoctoral Science Foundation (LBH-Q18099)
- University Nursing Program for Young Scholar with Creative Talents in Heilongjiang Province (UNPYSCT-2017059)
This publication has 67 references indexed in Scilit:
- Cancer‐associated missense mutations of caspase‐8 activate nuclear factor‐κB signalingCancer Science, 2013
- Notch controls generation and function of human effector CD8+ T cellsBlood, 2013
- Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinomaProceedings of the National Academy of Sciences, 2011
- PTEN Is a Major Tumor Suppressor in Pancreatic Ductal Adenocarcinoma and Regulates an NF-κB–Cytokine NetworkCancer Discovery, 2011
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- A Network Model of a Cooperative Genetic Landscape in Brain TumorsJAMA, 2009
- Notch Regulates Cytolytic Effector Function in CD8+ T CellsThe Journal of Immunology, 2009
- Positive and negative influences of regulatory T cells on tumour immunityOncogene, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000